Market Overview

Myomo Shares Move Lower; Colliers Reiterates Buy Rating, Increases Price Target From $7 To $8; Says New Medicare Provider Designation Is 'Important Step Ahead Of Potential Reimbursement Terms From CMS'

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for MYO

DateFirmActionFromTo
Sep 2020Colliers SecuritiesMaintainsBuy
Nov 2019Roth CapitalDowngradesBuyNeutral
Jul 2019Ascendiant CapitalInitiates Coverage OnBuy

View More Analyst Ratings for MYO
View the Latest Analyst Ratings

 

Related Articles (MYO)

Posted-In: Price Target Reiteration Analyst Ratings Movers Trading Ideas

Latest Ratings

StockFirmActionPT
TALUBSMaintains109.0
SPROEvercore ISI GroupInitiates Coverage On70.0
DYNTAegis CapitalMaintains1.7
WTBAPiper SandlerMaintains17.5
VRMPiper SandlerMaintains81.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com